A breast cancer diagnosis rarely arrives at a convenient moment. It arrives when you are managing work, children, parents, and a life that was not expecting to pause. Then come the questions about treatment, and the realisation, in Lagos or Accra, that the full pathway you need may not be accessible close to home. That is the moment many families begin looking at India. This guide is written for that moment.
Why West African Patients Come to India for Oncology
West Africa carries one of the heaviest breast cancer mortality burdens in the world. Not because the disease is more common here, but because most cases are diagnosed late, when treatment is harder, and because the complete infrastructure a modern breast cancer pathway requires is thinly distributed across the region. That gap costs lives that earlier access to treatment would save.
A complete breast cancer pathway needs multiple specialists working in coordination, reliably available drugs, functioning radiotherapy equipment, and accurate pathology. India's JCI-accredited private hospitals offer all of this. JCI accreditation is the same international standard applied to hospitals in the United States and Europe. It is not a marketing label.
Choosing to travel for treatment is not a sign your local doctors have failed you. It is a practical response to a gap in available infrastructure, one that thousands of Nigerian and Ghanaian families have navigated before you.
What Treatment in India Looks Like
When you arrive at a JCI-accredited Indian hospital, the oncology team re-evaluates your existing diagnosis before anything else. Indian oncologists do not simply accept a prior pathology report. They request their own review of biopsy slides and imaging, because staging and receptor status (ER, PR, HER2) directly determine the treatment plan. An error at this stage affects every decision that follows, so getting it right first matters.
From there, the pathway follows the same structure used in the UK, the United States, and other well-resourced health systems:
Surgery: lumpectomy (breast-conserving) or mastectomy, depending on tumour size, location, and stage. Reconstructive surgery can be performed at the same time or as a staged procedure.
Chemotherapy: given in cycles. Some patients complete all cycles in India; others begin in India and continue at home under a written protocol, returning for monitoring.
Radiotherapy: typically 15 to 25 sessions, depending on the protocol. Linear accelerators and image-guided radiotherapy are available at major partner centres.
Targeted therapy: for HER2-positive breast cancer, drugs including trastuzumab are part of standard care at accredited Indian centres.
Hormone therapy: prescribed for hormone receptor-positive disease and continued long-term after discharge. Your oncologist sets up a protocol you manage at home.
MediVenza's breast cancer treatment programme in India starts from $5,000 USD, covering the surgical and initial treatment package. Your total cost varies with cancer stage, treatment duration, and whether chemotherapy cycles are completed in India or partly at home.
The Visa and Arrival Process, Step by Step
The Indian Medical Visa authorises you to enter India specifically for medical treatment. Nigerian and Ghanaian passport holders are eligible. Follow the steps in order and the process is straightforward.
Step 1: Get your hospital invitation letter
You cannot apply for a Medical Visa without an invitation letter from the treating hospital. The hospital generates this through the Indian government's Medical and Ayush Visa Portal at indianfrro.gov.in/frro/medicalvaluetravel. You cannot produce this letter yourself. MediVenza coordinates it with the hospital once your case is accepted.
Step 2: Choose your visa type
Two routes are available. The e-Medical Visa is applied for online at indianvisaonline.gov.in. It is valid for 60 days from first arrival, allows three entries, and the application window opens 4 to 120 days before travel. For a breast cancer pathway of 6 to 12 weeks, the e-Medical Visa may cover a first trip, particularly if you plan to complete some treatment at home. The Regular Medical Visa, applied for through the Indian High Commission in your country, gives up to one year of validity with triple entry. If your treatment plan is longer, or you expect more than one trip, the Regular Medical Visa is the right choice.
Step 3: Book your vaccinations early
Nigerian and Ghanaian travellers to India must hold a Yellow Fever vaccination certificate issued at least 10 days before departure. Oral Polio Vaccination (OPV) is also mandatory and must be given at least 4 weeks before travel. The OPV timeline in particular requires planning well ahead, not in the final days before departure.
Step 4: Bring an attendant
You can bring up to two family members or companions on separate M-X Medical Attendant Visas. Their visa validity matches yours. You will need documentation of your relationship. Most patients travelling for oncology treatment bring at least one person. The practical and emotional support is significant, and Indian hospitals are set up for families to be present throughout treatment.
Step 5: Know the FRRO rule
If your stay in India exceeds 180 days, you must register with the Foreigners Regional Registration Office (FRRO) within 14 days of arrival. For most patients whose initial stay is 6 to 12 weeks, this will not apply to the first trip. It is still worth knowing before you go.
If you want a coordinator to walk through the documents with you before you start, MediVenza offers a free 24-hour assessment by enquiry.
What Happens Once You Arrive: A Realistic Timeline
Knowing the sequence before you land helps you plan around it: for work, for childcare, for family arrangements at home.
Days 1 to 3: arrival, admission, oncology consultation, re-evaluation of scans and pathology. Blood work, cardiology clearance if chemotherapy is planned, and a multidisciplinary treatment planning conference.
Days 4 to 10: surgery, if the plan begins with an operation. Most patients leave the surgical ward within 4 to 6 days of the procedure.
Weeks 2 to 6: surgical recovery, wound checks, first chemotherapy cycle if applicable, dietitian consultation, and physiotherapy where reconstruction was performed.
Weeks 6 to 12: continuation of chemotherapy cycles, radiotherapy where indicated, and regular oncology reviews. Some patients begin radiotherapy in India; others return for it on a second trip.
Before discharge: your oncologist prepares a full discharge summary covering the ongoing protocol: hormone therapy prescriptions, follow-up schedule, what to monitor, and when to seek help. This document is designed to be handed to a doctor at home.
The aim is not to replace your doctors at home. The aim is to ensure you receive the treatment your diagnosis requires, and that you leave with a clear written plan your local team can continue.
Honest Cost Framing
The $5,000 starting figure covers the surgical package at partner hospitals. It does not cover your full costs for a 6 to 12 week trip. Budget separately for these:
International flights for yourself and any attendants. Prices vary by departure city and how early you book.
Accommodation near the hospital for the period after inpatient discharge. Delhi has a wide range of hotels and serviced apartments; MediVenza can advise based on what other patients have used.
Chemotherapy and radiotherapy if these fall outside the initial surgical package. Your oncologist quotes these separately based on your staging and the number of cycles or sessions your plan requires.
Medications to take home. Many oncology drugs, including targeted therapies, cost considerably less in India than in Nigeria or Ghana. Some patients buy a supply before leaving.
Visa fees and vaccination costs: a modest but real item to include in your plan.
If you are managing more than one health concern, the full MediVenza treatments hub covers every procedure the team coordinates. Some families address more than one need in a single trip.
A breast cancer diagnosis demands clear decisions under difficult circumstances. India's oncology infrastructure is accredited, experienced with patients from Nigeria and Ghana, and delivers the full treatment pathway most patients need. Getting there is manageable, and MediVenza handles the coordination every day. To talk through your specific situation, reach the team on WhatsApp at +91 98996 55596 or through the contact page. Someone responds within 24 hours.
